Cargando…
Affordability of Medicines a Top Priority for EHA: Toward a Fair Pricing Model for Innovative Medicines
Autores principales: | Hagenbeek, Anton, Engert, Andreas, Kapitein, Peter, Doeswijk, Robin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745980/ https://www.ncbi.nlm.nih.gov/pubmed/31723741 http://dx.doi.org/10.1097/HS9.0000000000000012 |
Ejemplares similares
-
Fair Pricing of Innovative Medicines: An EHA Position Paper
por: Hagenbeek, Anton, et al.
Publicado: (2020) -
A Shared Drive: Securing Patient Access to High-Cost Medicines
por: van der Ent, Leendert
Publicado: (2017) -
Access to Affordable Orphan Medicines in Europe: An EHA Position Paper
por: Merlini, Giampaolo, et al.
Publicado: (2020) -
Personalized Treatment for Hematologic Diseases in Europe: An EHA Position Paper
por: Jäger, Ulrich, et al.
Publicado: (2020) -
EU-Wide Access to High-quality, Affordable Precision Diagnostics: An EHA Position Paper
por: Macintyre, Elizabeth, et al.
Publicado: (2020)